This is why you're suddenly shedding 200-300 hairs a day instead of the normal 50-100
The objective of our study is to assess the risk of developing erectile dysfunction after semaglutide is prescribed for weight loss in obese, non-diabetic men
Libido isn't an isolated switch
NICE has approved specific GLP-1 medications for obesity treatment (liraglutide 3mg/Saxenda and semaglutide 2.4mg/Wegovy), but access through the NHS is restricted to specialist weight management services, and waiting lists can be substantial
Safety, tolerability, pharmacokinetics, and pharmacodynamics of the first-in-class GLP-1 and amylin receptor agonist, amycretin: a first-in-human, phase 1, double-blind, randomised, placebo-controlled trial
Liang GB, Du GC, Chen J (2008a) A novel strategy of enhanced glutathione production in high cell density cultivation of Candida utilis cysteine addition combined with dissolved oxygen controlling